Division of Infectious Diseases

November 16, 2023

Nasty microbe H. pylori has Achilles’ heel

Vanderbilt researchers found that an H. pylori enzyme is essential for colonization of the stomach, suggesting it as a promising therapeutic target for H. pylori infection.

By Paul Govern
October 26, 2023

Karen Bloch honored for clinical excellence by Infectious Diseases Society of America

Vanderbilt’s Karen Bloch, MD, MPH, is one of two winners of the 2023 Watanakunakorn Clinician Award from the Infectious Disease Society of America.

By Paul Govern
October 25, 2023

Immune system’s role in metabolic disease detailed in tissue atlas

Researchers at Vanderbilt University Medical Center have published the largest known single-site adipose tissue atlas — a comprehensive, detailed map of the cells, structures and molecules within a specific tissue or organ, designed to support open-ended study.

By Paul Govern
ELVIS team leaders include, from left, Jane Freedman, MD, project leader Suman Das, PhD, Simon Mallal, MBBS, Ravi Shah, MD, John McLean, PhD. (photo by Erin O. Smith)
September 19, 2023

$51 million NIH grant brings ELVIS to VUMC

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.

By Paul Govern
June 14, 2023

NIH grant boosts international TB research consortium

A new grant will help support Vanderbilt’s RePORT Brazil, one of an international consortium’s six regional tuberculosis research programs.

By Paul Govern
May 24, 2023

VUMC app used by research participants around the world

MyCap is a secure, customizable mobile computing application (for smartphone or tablet) used to collect data from research participants on a remote basis.

At Vanderbilt University Medical Center, where MyCap was created and launched in 2018, some 107 projects have used the app, and by 2021, research participants in 135 countries had installed the free app.

By Paul Govern
May 8, 2023

Harris named Department of Medicine’s executive vice chair for Clinical Affairs

Bryan Harris, MD, MPH, MMHC, has been named executive vice chair for Clinical Affairs for Vanderbilt's Department of Medicine, effective July 1.
By Jill Clendening
April 27, 2023

Phillips elected to Association of American Physicians

Vanderbilt's Elizabeth Phillips, MD, has been elected to membership in the Association of American Physicians
By Bill Snyder
April 25, 2023

COVID alters respiratory microbiota

COVID-19 infection alters the microbes of the upper respiratory tract for at least several weeks, and such disturbances could impact disease severity and be targets for therapeutic interventions.
By Leigh MacMillan
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.
By Bill Snyder
February 23, 2023

NIH grant supports TB research network in Brazil

The National Institutes of Health has awarded a five-year, $5 million grant to Vanderbilt University Medical Center for continued support of the Brazil Regional Prospective Observational Research in Tuberculosis network, or RePORT-Brazil.
By Paul Govern
February 8, 2023

New Chief Medical Officers announced

Rick W. Wright, MD, has been appointed as Vanderbilt University Medical Center’s new Chief Medical Officer (CMO) and Senior Vice President for Clinical Affairs and Patty Wright, MD, will be transitioning from her role as Chief of Staff for Adult Ambulatory, Davidson County to the role of Chief Medical Officer for Adult Ambulatory Clinics.
By John Howser
February 6, 2023

Gut microbiota and lung fibrosis

Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.
By Leigh MacMillan
1 2 3 4 … 12